IndraLab

Statements



reach
"Interestingly, similar to bortezomib, the next generation proteasome-inhibitors carfilzomib and ixazomib, as well as the investigational proteasome inhibitor MG-132 also triggered generation of Mcl-1 [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Either cycloheximide (CHX) or the cysteine protease inhibitor, MG132, restored the responsiveness of p39 to growth factors in nutrient starved cells."